Bone Arches: Performance of Pseudo-scanner Sequences in Segmenting the Extent of the Tumour and in Planning Surgical Resection Using the CT Scan as a Reference
Launched by CLINIQUES UNIVERSITAIRES SAINT-LUC- UNIVERSITÉ CATHOLIQUE DE LOUVAIN · May 15, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Bone Arches," is investigating a new type of MRI scan called "pseudo-scanner" sequences to see how well it can help identify the size and location of bone tumors, specifically sarcomas. The aim is to find out if this new imaging method can replace traditional CT scans during surgery, which would help reduce the amount of radiation exposure that patients receive. By using this MRI technique, doctors hope to improve the planning of surgical procedures and make surgeries safer and more effective.
To participate in this trial, you must have a diagnosis of bone sarcoma and need surgery for it. Unfortunately, if you have any implants that aren’t safe for MRI, suffer from severe claustrophobia, or are pregnant, you won’t be eligible to join. If you qualify, you can expect to undergo this new MRI imaging technique, which may help your doctors better understand your tumor and plan your surgery in a more precise way. This study is currently not recruiting participants yet, but it aims to potentially bring a safer option for patients with bone sarcomas in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diagnosis of bone sarcoma with surgical indication
- Exclusion Criteria:
- • Implanted material incompatible with MRI.
- • Severe claustrophobia.
- • Pregnant women
About Cliniques Universitaires Saint Luc Université Catholique De Louvain
Cliniques Universitaires Saint-Luc, affiliated with the Université Catholique de Louvain, is a leading academic medical center in Belgium dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, it focuses on a wide range of therapeutic areas, prioritizing patient safety and ethical standards. The institution is committed to fostering collaboration between researchers and clinicians to enhance medical knowledge and improve treatment outcomes, contributing significantly to the global scientific community and the advancement of evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brussels, , Belgium
Brussels, , Belgium
Patients applied
Trial Officials
Frédéric Lecouvet
Principal Investigator
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported